Emergency treatment of anaphylactic reactions;Akuttherapie anaphylaktischer reaktionen

Allergo Journal

Volumn 16, Issue 6, 2007, Pages 420-434

  Ring, Johannes ^a   Brockow, Knut ^a   Duda, Dorothea ^b   Eschenhagen, Thomas ^c   Fuchs, Thomas ^d   Huttegger, Isidor ^e   Kapp, Alexander ^f   Klimek, Ludger ^g   Müller, Ulrich ^h   Niggemann, Bodo ⁱ   Pfaar, Oliver ^g   Przybilla, Bernhard ^j   Rebien, Wolfgang ^k   Rietschel, Ernst ^l   Ruëff, Franziska ^j   Schnadt, Sabine ^m   Tryba, Michael ⁿ   Worm, Margitta ⁱ   Sitter, Helmut ^o   Schultze Werninghaus, Gerhard ^p  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b St Hildegardis Krankenhaus   (Germany)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d UNIVERSITY OF GÖTTINGEN   (Germany)

^e Salzburger Landeskliniken   (Austria)

^f HANNOVER MEDICAL SCHOOL   (Germany)

^g Zentrum fur Rhinologie und Allergologie   (Germany)

^h Spitalnetz Bern   (Switzerland)

ⁱ CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^j LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^k Klinik für Allgemeine Kinderheilkunde und Jugendmedizin   (Germany)

^l UNIVERSITY OF COLOGNE   (Germany)

^m Deutscher Allergie und Asthmabund   (Germany)

ⁿ KLINIKUM KASSEL   (Germany)

^o PHILIPPS UNIVERSITY MARBURG   (Germany)

^p RUHR UNIVERSITY BOCHUM   (Germany)

more..

Author keywords

Anaphylaxis; Antihistamines; Catecholamines, epinephrine; Emergency treatment; Glucocorticoids

Indexed keywords

ANTIHISTAMINIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DOPAMINE; GLUCOCORTICOID; NORADRENALIN; VASOPRESSIN;

ALGORITHM; ANAPHYLAXIS; EMERGENCY TREATMENT; HOSPITAL ADMISSION; HUMAN; IMMUNOLOGY; PATIENT CARE; REVIEW; SELF MEDICATION;

EID: 35349018009     PISSN: 09418849     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03370705     Document Type: Review

References (105)

1. 2- Rezeptorantagonisten. J Mol Med 1989; 67: 743-55
2. Barnard JH. Studies of 400 Hymenoptera sting deaths in the United States. J Allergy Clin Immunol 1973; 52: 259-64
3. Bellomo R, Chapman M, Finfer S, Hickling K, Myburth J. Low-dose dopamine in patients with early renal dysfunctions placebo-controlled randomised trial. Autralian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Lancet 2000; 356: 2139-43
4. Berchtold E, Maibach R, Müller U. Reduction of side effects from rush-immunotherapy with honeybee venom by pretreatment with terfenadine. Clin Exp Allergy 1991; 22: 59-65
5. Boldt J. Volumenersatz beim schwerkranken Intensivpatienten. Anaesthesist 1998; 47: 778-85
6. Boldt J, Priebe H-J. Intravascular volume replacement therapy with synthetic colloids: is there an influence on renal function? Anesth Analg 2003; 96: 376-82
7. Bresser H, Sander CH, Rakoski J. Insektenstichnotfälle in München. Allergo J 1995; 4: 373-6
8. Brockow K, Vieluf D, Puschel K, Grosch J, Ring J. Increased postmortem serum mast cell tryptase in a fatal anaphylactoid reaction to nonionic radiocontrast medium. J Allergy Clin Immunol 1999; 104: 237-8
9. Brown MJ, Brown DC, Murphy MB. Hypokalemia from beta-2 receptor stimulation by circulating epinephrine. N Engl J Med 1983; 309: 1414-9
10. Brown SG, Blackman KE, Stenlake V, Heddle RJ. Insect sting anaphylaxis: prospective evaluation of treatment with intravenous adrenaline and volume resuscitation. Emerg Med J 2004; 21: 149-54
11. Capurro N, Levi R. The heart as target organ in systemic allergic reactions. Circ Res 1975; 36: 520-8
12. Celik I. Renal dysfunction after hydroxyethyl starch. Letter to the Editor. In response: Boldt J, Priebe H-J. Anesth Analg 2004; 99: 309-10
13. Celik I, Duda D, Stinner B, Kimura K, Gayek H, Lorenz W. Early and late histamine release induced by albumin, hetastarch and polygeline: some unexpected findings. Inflamm Res 2003; 52: 408-16
14. Celik I, Lorenz W, Stinner B, Duda D, Sitter H, Sauer S, Junge A, Hoppe M. Clinical modeling randomised trials (CMRT's) in animals as a new intermediate between biological experiments and randomised clinical trials: application to antihistamine prophylaxis in anaesthesia and surgery. Inflamm Res 1998; 47 (Suppl 1): S66-8
15. Clark S, Bock SA, Gaeta TJ, Brenner BE, Cydulka RK, Camargo CA. Multicenter study of emergency department visits for food allergies. J Allergy Clin Immunol 2004; 113: 347-52
16. Clough GF, Boutsiouki P, Church MK. Comparison of the effects of levocetirizine and loratadine on histamine-induced wheal, flare, and itch in human skin. Allergy 2001; 56: 985-8
17. Crifo G, Bircher A. Selbstbehandlung mit Notfallmedikamenten. Allergologie 2003; 26: 1516-23
18. Delage C, Irey HC. Anaphylactic deaths: a clinicopathologic study of 43 cases. J Forensic Sci 1972; 17: 525
19. th Congress of the European Resuscitation Council. Bologna: Monduzzi, 1998: 15-9
20. Eisenberg MS, Mengest TJ. Cardiac resuscitation. N Engl J Med 2001; 344: 1304-13
21. Ellis AK, Day JH. Diagnosis and management of anaphylaxis. Can Med Assoc J 2003; 169: 307-11
22. Endrich B, Ring J, Intaglietta M. Effects of radiopaque contrast media on the microcirculation of the rabbit omentum. Radiology 1979; 132: 331-9
23. Fisher MMD. Clinical observations on the pathophysiology and treatment of anaphylactic cardiovascular collapse. Anesth Intensive Care 1986; 17: 17-21
24. Friedrich JO, Adhikari N, Herridge MS, Beyene J. Meta-analysis: low-dose dopamine increases urine output but does not prevent renal dysfunction or death. Ann Intern Med 2005; 142: 510-24
25. 1-mediated negative chronotropic and inotropic effects on human atrial myocardium. J Pharmacol Exp Ther 1988; 247: 844-9
26. Grant JA, Riethuisen JM, Moulaert B, DeVos C. A double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects. Ann Allergy Asthma Immunol 2002; 88: 190-7
27. Greenberger PA, Patterson R. The prevention of immediate generalized reactions to radiocontrast media in high-risk patients. J Allergy Clin Immunol 1991; 87: 867-72
28. Gronemeyer W. Noradrenalin statt Adrenalin beim anaphylaktischen Schock. Dtsch Med Wochenschr 1980; 102: 101
29. Gu X, Simons KJ, Simons FER. Administration by sublingual tablet feasible for the first aid treatment of anaphylaxis? A proof-of-concept study. Diophar Drug Dispos 2002; 23: 213-6
30. Hannaway PJ, Hoppler GDK. Severe anaphylaxis and drug induced beta-blockage. N Engl J Med 1983; 308: 1536
31. Helbing A, Hurni T, Müller UR, Pichler WJ. Incidence of anaphylaxis with circulatory symptoms: a study over a 3-year period comprising 940,000 in habitants of the Swiss Canton Bern. Clin Exp Allergy 2004; 34: 285-90
32. Hepner DL, Castells MC. Anaphylaxis during the perioperative period. Anesth Analg 2003; 97: 1381-95
33. Hepner MJ, Ownby DR, Anderson JA, Rowe MS, Sears-Ewald D, Brown EB. Risk of systemic reactions in patients taking beta-blocker drugs receiving immunotherapy injections. J Allergy Clin Immunol 1990; 86: 407-11
34. Hermann K, Ring J. The renin-angiotensin system in patients with repeated anaphylactic reactions during Hymenoptera venom hyposensitization and sting challenge. Int Arch Allergy Immunol 1997; 11: 251-6
35. Hoffmann BB. Catecholamines, sympathomimetic drugs and adrenergic receptor anatagonists. In: Hardman JG, Limbird LE, Goodman A, eds. Goodman & Gilman: The Pharmaceutical Basis of Therapeutics. New York: McGraw Hill, 2002: 215-68
36. Holgate ST, Canonica GW, Simons FE, Taglialatela M, Tharp M, Timmerman H, Yanai K. Consensus Group on New-Generation Antihistamines (CONGA): present status and recommendations. Clin Exp Allergy 2003; 33: 1305-24
37. Ickx BE, Bepperling F, Melot C, Schulman C, Linden PJ van der. Plasma substitution effects of a new hydroxyethyls starch HES 130/0.4 compare with HES 200/0.5. Br J Anaesth 2003; 91: 196-202
38. Johansson SGO, Bieber T, Dahl R, Friedmann PS, Lanier BQ, Lockey RF, Motala C, Martell JAO, Platts-Mills TAE, Ring J, Thien F, Cauwenberge PV, Williams HC. Revised nomenclature for allergy for global use: report of the nomenclature review committee of the World Allergy Organization. J Allergy Clin Immunol 2004; 113: 832-6
39. Joint Task Force on Practice Parameters; American Academy of Allergy, Asthma and Immunology; American College of Allergy, Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology. The diagnosis and management of anaphylaxis: an updated practice parameter. J Allergy Clin Immunol 2005; 115 (Suppl 2): S483-523
40. Kaiser H, Kley H, Hrsg. Cortisontherapie - Corticoïde in Klinik und Praxis. Stuttgart-New York: Thieme, 2002
41. Kasper SM, Meinert P, Görg C, Mehlhorn U, Diefenbach C. Large-dose hydroxyethyl starch (HES) 130/0.4 in elective coronary artery bypass surgery. Crit Care 2002; 6: 173
42. Kemp SF, Lockey RF. Anaphylaxis: a review of causes and mechanisms. J Allergy Clin Immunol 2002; 110: 341-8
43. Kill C, Wranze E, Wulf H. Successful treatment of severe anaphylactic shock with vasopressin. Two case reports. Int Arch Allergy Immunol 2004; 134: 260-1
44. Kleine-Tebbe J, Fuchs T, Klimek L, Kühr J, Lepp U, Niggemann B, Rakoski J, Renz H, Saloga J, Simon J. Die spezifische Immuntherapie (Hyposensibilisierung) mit Allergenen. Positionspapier der Deutschen Gesellschaft für Allergologie und klinische Immunologie. Allergo J 2000; 9: 317-24
45. Kleinhans D. Anstrengungsinduzierte Urtikaria und Anaphylaxie. Med Klin 1987; 82: 103-4
46. Laine-Cessac P, Moshinaly H, Gouello JP, Geslin P, Allain P. Severe anaphylactoid reaction after intravenous corticosteroids. Report of a case and review of the literature. Therapie 1990; 45: 505-8
47. Laubenthal H. Dextrananaphylaxie, Pathomechanismus und Prophylaxe. Ergebnisse einer multizentrischen Studie. Berlin - Heidelberg - New York: Springer, 1986
48. Lieberman P. Use of epinephrine in the treatment of anaphylaxis. Curr Opin Allergy Clin Immunol 2003; 3: 313-8
49. 2 antagonists. Ann Emerg Med 2000; 36: 462-8
50. Lockey RF, Benedict LM, Turkeltaub TB, Bukantz SC. Fatalities from immunotherapy (IT) and skin testing (ST). J Allergy Clin Immunol 1987; 79: 666-77
51. Lorenz W, Duda D, Dick W, Sitter H, Doenicke A, Black A, Weber D, Menke H, Stinner B, Junginger T, Rothmund M, Ohmann Ch, Healy MJR. Incidence and clinical importance of perioperative histamine release: randomised study of volume loading and antihistamines after induction of anaesthesia. Lancet 1994; 343: 933-40
52. Lorenz W, Ennis M, Doenicke A, Dich W. Perioperative uses of histamine antagonists. J Clin Anesth 1990; 2: 345-60
53. Ludolph-Hauser D, Ruëff F, Fries C, Schöpf P, Przybilla B. Constitutively raised serum concentrations of mast cell tryptase and severe anaphylactic reactions to Hymenoptera stings. Lancet 2001; 357: 361-2
54. Marone G, Bova M, Detoraki A, Onorati AM, Rossi FW, Spadaro G. The human heart as a shock organ in anaphylaxis. Novartis Found Symp 2004; 257: 133-49
55. Maulitz RM, Pratt DS, Schocket AL. Exercise-induced anaphylactic reaction to shellfish. J Allergy Clin Immunol 1979; 63: 433
56. Mehl A, Wahn U, Niggemann B. Anaphylactic reactions in children - a questionnaire-based survey in Germany. Allergy 2005; 60: 1440-5
57. Meßmer K. Plasma substitutes and indications for their use. In: Tinker J, Rapin M, eds. Care of the Critically Ill Patient. Berlin - Heidelberg - New York: Springer, 1983: 569-75
58. Moneret-Vautrin DA, Morisset M, Flabbee J, Beaudouin E, Kanny G. Epidemiology of life-threatening and lethal anaphylaxis: a review. Allergy 2005; 60: 443-51
59. Müller U. Spätkomplikationen bei Anaphylaxie. In: Ring J, Darsow U, Hrsg. Aliergie 2000: Probleme, Strategien und praktische Konsequenzen. München: Dustri, 2001: 249-52
60. Müller U, Haeberli G. Use of beta-blockers during immunotherapy for Hymenoptera venom allergy. J Allergy Clin Immunol 2005; 115: 606-10
61. Müller U, Mosbech H, Blaauw P, Dreborg S, Malling HJ, Przybilla B, Urbanek R, Pastorello E, Blanca M, Bousquet J, Jarisch R, Youlten L. Emergency treatment of allergic reactions to Hymenoptera stings. Clin Exp Allergy 1991; 21: 281-8
62. Nielsen L, Johnsen CR, Mosbech H, Poulsen LK, Malling HJ. Antihistamine premedication in specific cluster immunotherapy: a double-blind, placebo-controlled study. J Allergy Clin Immunol 1996; 97: 1207-13
63. Pavek K, Wegmann A, Nordström L, Schwander D. Cardiovascular and respiratory mechanisms in anaphylactic and anaphylactoid shock reactions. Klin Wochenschr 1982; 60: 941-7
64. Portier P, Richet C. De l'action anaphylactique de certains venins. C R Soc Biol 1902; 54: 170
65. Przybilla B, Ring J. Anaphylaxis to ethanol and sensitization to acetic acid. Lancet 1983; 1: 483
66. Przybilla B, Ruëff F, Fuchs T, Pfeiffer C, Rakoski J, Stolz W, Vieluf D. Insektengiftallergie. Leitlinie der Deutschen Gesellschaft für Allergologie und klinische Immunologie. Allergo J 2004; 13: 186-90
67. Pumphrey RS. Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy 2000; 30: 1144-50
68. Ranft A, Kochs EF. Therapie anaphylaktischer Reaktionen: Synopsis bestehender Leitlinien und Empfehlungen. Anästhesiol Intensivmed Notfallmed Schmerzther 2004; 39: 2-9
69. Reimers A, Müller U. Behandlung des anaphylaktischen Schocks. Ther Umsch 2000; 58: 325-8
70. Richet C. De l'anaphylaxie ou sensibilité croissante des organismes à des doses successives de poison. Arch Fisiol 1904; 1: 129
71. Richter W, Hedin H, Ring J, Kraft D, Messmer K. Anaphylaktoide Reaktionen nach Dextran I. Immunologische Grundlagen und klinische Befunde. Allergologie 1980; 3: 9
72. Ring J. Angewandte Allergologie, 3. Aufl. München: Urban & Vogel, 2004
73. Ring J, Behrendt H. Anaphylaxis and anaphylactoid reactions. Classification and pathophysiology. Clin Rev Allergy Immunol 1999; 17: 387-99
74. Ring J, Darsow U. Idiopathic anaphylaxis. Curr Allergy Asthma Rep 2002; 2: 40-5
75. Ring J, Messmer K. Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet 1977; 1: 466-9
76. 2-receptor antagonists: results of a prospective controlled trial. Int Arch Allergy Appl Immunol 1985; 78: 9-14
77. Rohrer CL, Pichler WJ, Helbling A. Anaphylaxie: Klinik, Ätiologie und Verlauf bei 118 Patienten. Schweiz Med Wochenschr 1998; 128: 53-63
78. Sampson HA, Muñoz-Furlong A, Bock SA, Schmitt C, Bass R, Chowdhury BA, Decker WW, Furlong TJ, Galli SJ, Golden DB, Gruchalla RS, Harlor AD, Hepner DL, Howarth M, Kaplan AP, Levy JH, Lewis LM, Lieberman PL, Metcalfe DD, Murphy R, Pollart SM, Pumphrey RS, Rosenwasser LJ, Simons FE, Wood JP, Camargo CA. Symposium on the definition and management of anaphylaxis: summary report. J Allergy Clin Immunol 2005; 115: 584-91
79. Schmittinger CA, Wenzel V, Herff H, Stadlbauer KH, Krismer AC, Voelckel WG, Strohmenger HU, Lindner KH. Medikamentöse Therapie der kardiopulmonalen Reanimation. Anästhesiol Intensivmed Notfallmed Schmerzther 2003; 38: 651-75
80. Schwartz L. Clinical utility of tryptase levels in systemic mastocytoses and associated hematologic disorders. Leuk Res 2001; 25: 553-62
81. Sheikh A, Alves B. Hospital admissions for acute anaphylaxis: time trend study. BMJ 2000; 320: 1441
82. Simons FE. Comparative pharmacology of H, antihistamines: clinical relvance. Am J Med 2002; 113 (Suppl 9A): 38-46
83. 1-antihistamines: more relevant than ever in the treatment of allergic disorders. J Allergy Clin Immunol 2003; 112: 42-52
84. 1-antihistamines. N Engl J Med 2004; 351: 2203-17
85. Simons FE. First-aid treatment of anaphylaxis to food: focus on epinephrine. J Allergy Clin Immunol 2004; 113: 837-44
86. 1-antihistamines in the skin. J Allergy Clin Immunol 2002; 110: 777-83
87. Simons FER, Gu X, Jounston L, Simons KJ. Can epinephrine inhalations be substituted for epinephrine injection in children at risk for systemic anaphylaxis? Pediatrics 2000; 106: 1040-4
88. Simons FER, Gu X, Simons KJ. Epinephrine absorption in adults: intramuscular versus subcutaneous injection. J Allergy Clin Immunol 2001; 108: 871-3
89. Smedegard G, Revenäs B, Arfors KE. Anaphylaxis in the monkey: hemodynamics and blood flow distribution. Acta Physiol Scand 1979; 106: 191
90. Smith PL, Kagey-Sobotka A, Blecker ER, Traystman R, Kaplan AP, Gralink H, Valentine MD, Permut S, Lichtenstein LM. Physiologic manifestations of human anaphylaxis. J Clin Invest 1980; 60: 1072
91. Soto H de, Turk P. Cimetidine in anaphylactic shock refractory to standard therapy. Anesth Analg 1990; 69: 264-5
92. Stark BJ, Sullivan TJ. Biphasic and protracted anaphylaxis. J Allergy Clin Immunol 1986; 78: 76-83
93. Stoelting RK. Systemic circulation. In: Stoetting RK, eds. Pharmacology & Physiology in Anesthetic Practice. Philadelphia: Lippincott, 2006: 661-78
94. Stumpf JL, Shehab N, Patel AC. Safety of angiotensin-converting enzyme inhibitors in patients with insect venom allergies. Ann Pharmacother 2006; 40: 699-703
95. Sullivan TJ. Cardiac disorders in penicillin-induced anaphylaxis: association with intravenous epinephrine therapy. JAMA 1982; 248: 2161
96. Suttner S, Boldt J. Beeinflusst die Gabe von Hydroxyethylstärke die Nierenfunktion? Anästhesiol Intensivmed Notfallmed Schmerzther 2004; 39: 71-7
97. TenBrook JA, Wolf MP, Hoffmann SN, Rosenwasser LJ, Konstam MA, Salem DN. Should beta-blockers be given to patients with heart disease and peanut-induced anaphylaxis? A decision analysis. J Allergy Clin Immunol 2004; 113: 977-82
98. Toogood HH. Risk of anaphylaxis in patients receiving beta-blocker drugs. J Allergy Clin Immunol 1988; 81: 1-5
99. Tryba M. Therapie des anaphylaktischen Schocks. Notfallmedizin 1997; 23: 238-44
100. Tryba M, Ahnefeld FW, Barth J, Dick W, Doenicke A, Fuchs T, Gervais H, Laubenthal H, Löllgen H, Lorenz W, Mehrkens HH, Meuret GH, Möllmann H, Piepenbrock S, Przybilla B, Ring J, Schmutzler W, Schultze-Werninghaus G, Schüttler J, Schuster JP, Sefrin P, Zander J, Zenz M. Akuttherapie anaphylaktoider Reaktionen. Ergebnisse einer interdisziplinären Konsensuskonferenz. Allergo J 1994; 3: 211-24
101. Waldhausen E, Keser G, Marquardt B. Der anaphylaktische Schock. Anästhesist 1987; 36: 150-8
102. Walther A, Bottiger BW. Anaphylaktoide Reaktionen in der Prähospitalphase. Internist (Berl) 2004; 45: 296-304
103. Winbery SL, Lieberman PL. Histamine and antihistamines in anaphylaxis. Clin Allergy Immunol 2002; 17: 287-317
104. Wüthrich B, Ballmer-Weber BK. Food-induced anaphylaxis. Allergy 2001; 56 (Suppl 67): 102-4
105. Zaloga GP, Delacey W, Holmboe E, Chernow B. Glucagon reversal of hypotension in a case of anaphylactoid shock. Ann Intern Med 1986; 105: 65-6